208 results
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
Intoxication patients presenting to the emergency department combined with a larger THC challenge study in volunteers could potentially provide substantial
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
Intoxication patients presenting to the emergency department combined with a larger THC challenge study in volunteers could potentially provide substantial
8-K
EX-10.1
zp2u4sgr0x covwr2jme
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
S-3ASR
EX-1.2
vj7x4 q77a
30 Sep 22
Automatic shelf registration
4:17pm
425
k2gzxyr
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.2
rcxsrao
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
pz5w2ny
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-99.1
8k0gnr0b5gxjl liruo
9 Nov 21
Ligand Reports Third Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
mt9zeq rj
14 Jul 21
Ligand Pharmaceuticals Appoints Dr. Jennifer Cochran to its Board of Directors
4:08pm
8-K/A
EX-99.1
54do17e4
10 Dec 20
Financial Statements and Exhibits
4:13pm